A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2011
11/30/2011	EP2389951A1 Anti-tumor cell antigen antibody therapeutics
11/30/2011	EP2389950A1 Anti-tumor cell antigen antibody therapeutics
11/30/2011	EP2389949A1 Anti-tumor cell antigen antibody therapeutics
11/30/2011	EP2389948A1 Anti-tumor cell antigen antibody therapeutics
11/30/2011	EP2389947A1 Anti-tumor cell antigen antibody therapeutics
11/30/2011	EP2389946A1 Anti-tumor cell antigen antibody therapeutics
11/30/2011	EP2389943A1 Use of IL-174 antagonists for treating Th2-related diseases
11/30/2011	EP2389433A2 Mycoplasma gallisepticum formulation
11/30/2011	EP2389393A1 Anti-cd 160 monoclonal antibodies and uses thereof
11/30/2011	EP2389392A1 Methods for producing mixtures of antibodies
11/30/2011	EP2389195A1 Antibody mediated osseous regeneration
11/30/2011	EP2389194A2 Systems and methods to facilitate electronic payments
11/30/2011	EP2389193A1 Compositions and methods for induction of antigen-specific tolerance
11/30/2011	EP2389192A2 Stabilized fc polypeptides with reduced effector function and methods of use
11/30/2011	EP2117592B1 Methods and compositions for depleting specific cell populations from blood tissues
11/30/2011	EP2007419B1 Vaccine against mycoplasma prrsv
11/30/2011	EP1924604B1 Human monoclonal antibodies that specifically bind igf-ii
11/30/2011	EP1879613B1 Peptide conjugate compositions and methods for the prevention and treatment of alzheimer's disease
11/30/2011	EP1801231B1 Method of screening baff suppressor or inhibitor
11/30/2011	EP1778186B1 Method for preparation of poly-iclc and uses thereof
11/30/2011	EP1633372B1 Vaccines, immunotherapeutics and methods for using the same
11/30/2011	EP1585966B1 Treatment of cancer with the anti-ErbB2 antibody rhuMAb 2C4
11/30/2011	EP1573012B1 Recombinant viral-based malaria vaccines
11/30/2011	EP1503799B1 Immunogenic, monoclonal antibody
11/30/2011	EP1392360B1 Modified antibodies to prostate-specific membrane antigen and uses thereof
11/30/2011	EP1305042B1 Compositions comprising non-typable Haemophilus influenzae (NTHI) and probiotic bacteria for the treatment of mucosal infections caused by NTHI
11/30/2011	CN1849138B 作为选择性ngf途径抑制剂的人抗ngf中和抗体 Ngf pathway inhibitors as selective human anti ngf neutralizing antibodies
11/30/2011	CN102264909A 单重组体系及其使用方法 Single recombination system and method of use
11/30/2011	CN102264897A Rab6kifl/kif20a表位肽及包含它的疫苗 Rab6kifl / kif20a epitope peptide vaccine that contains it
11/30/2011	CN102264896A 抗人流感病毒人型抗体 Human anti-human influenza virus antibodies
11/30/2011	CN102264891A Th2细胞诱导用组合物和Th2型疾病的治疗组合物、以及该组合物的利用 Th2 cells induce therapeutic composition compositions and Th2-type diseases, as well as the composition of use
11/30/2011	CN102264765A 抗muc1抗体 Antibody anti muc1
11/30/2011	CN102264763A 定向于dll4的抗体及其用途 Directed antibodies and their use in dll4
11/30/2011	CN102264762A 人抗pd-1、pd-l1和pd-l2的抗体及其应用 Human anti-pd-1, pd-l1 and pd-l2 antibodies and Applications
11/30/2011	CN102264759A 与蛋白a的结合改变的免疫球蛋白变体 With a protein A binding altered immunoglobulin variants
11/30/2011	CN102264444A 纯化方法 Purification methods
11/30/2011	CN102264394A 脂化咪唑并喹啉衍生物 Lipidated imidazoquinoline derivative
11/30/2011	CN102264393A 作为治疗和预防hcv感染药物的抗hcv单克隆抗体 As the treatment and prevention of drug resistance hcv hcv infection monoclonal antibodies
11/30/2011	CN102264392A 免疫球蛋白纯化 Immunoglobulin purification
11/30/2011	CN102264391A 工程化抗il-13抗体、组合物、方法和用途 Engineered anti-il-13 antibodies, compositions, methods and uses
11/30/2011	CN102264390A Il6免疫治疗 Il6 immunotherapy
11/30/2011	CN102264389A 适用于结核病初级预防的免疫治疗剂 Suitable for primary prevention of tuberculosis immunotherapeutic agent
11/30/2011	CN102264388A 含有特异性识别cd38的抗体和长春新碱的抗肿瘤组合 Anti-tumor composition comprising an antibody that specifically recognize cd38 and vincristine
11/30/2011	CN102264387A 含有特异性识别cd38的抗体和环磷酰胺的抗肿瘤组合 Anti-tumor composition comprising an antibody that specifically recognize cd38 and cyclophosphamide
11/30/2011	CN102264386A 含特异性识别cd38的抗体和阿糖胞苷的抗肿瘤组合 Containing a combination of anti-tumor antibodies that specifically recognize and cytarabine cd38
11/30/2011	CN102264385A 含特异性识别cd38的抗体和苯丙氨酸氮芥的抗肿瘤组合 Anti-tumor composition containing an antibody that specifically recognizes cd38 and melphalan
11/30/2011	CN102264384A 类风湿关节炎、颤抖症/帕金森氏症、多发性硬化症和非病毒型癌症的治疗方法 Treatment of rheumatoid arthritis, tremor / Parkinson's disease, multiple sclerosis and non-viral cancers
11/30/2011	CN102264381A 提供对疟原虫的长效免疫应答的用于疟疾的多组分疫苗 Provides long-lasting immune response to Plasmodium multicomponent vaccine for malaria
11/30/2011	CN102264373A 用于原位肿瘤破坏疗法的免疫刺激性皂苷类 Therapy for in situ tumor destruction immunostimulatory saponins
11/30/2011	CN102264368A 极光激酶抑制剂与抗cd20抗体的组合 Aurora kinase inhibitor in combination with an anti-cd20 antibody
11/30/2011	CN102260649A 传染性法氏囊病毒及用鸡胚细胞系和生物反应器繁殖法氏囊病毒制备灭活疫苗和联苗的方法 Infectious bursal disease virus and method chick embryo cell line and bioreactor breeding bursa and associated preparation of inactivated vaccine virus vaccine
11/30/2011	CN102260648A 重组鼠骨髓瘤细胞ns0-f10及其应用 Recombinant murine myeloma cells and its application ns0-f10
11/30/2011	CN102260351A 流感病毒M2e蛋白的制备及其在抗甲型流感病毒中的应用 Preparation of influenza virus M2e protein and its application in anti-influenza viruses
11/30/2011	CN102260350A 人鼠嵌合型抗人CD14抗体Hm2F9及用途 Human-mouse chimeric anti-human CD14 antibodies and uses Hm2F9
11/30/2011	CN102260349A 用于治疗和预防阿尔茨海默病的抗Aβ31-35抗体及其制备方法 Anti Aβ31-35 antibody treatment and prevention of Alzheimer's disease and its preparation method
11/30/2011	CN102260322A 幽门螺杆菌抗原肽及其应用 Helicobacter pylori antigen peptide and its application
11/30/2011	CN102258784A 用于预防和治疗败血症的方法与组合物 For the prevention and treatment of sepsis methods and compositions
11/30/2011	CN102258781A 一种治疗肝癌的靶向药物组合物 A method of treating liver cancer targeted drug composition
11/30/2011	CN102258780A 一种螨变应原冻干疫苗及其制备方法 One kind of mite allergen lyophilized vaccine and its preparation method
11/30/2011	CN102258779A 四种及四种以上hiv载体基因疫苗序贯及重复应用 Four kinds of hiv carriers and more than four sequential and repeated applications of gene vaccine
11/30/2011	CN102258778A 生物分子表面展示及其用途 Biomolecular surface display and uses
11/30/2011	CN102258777A 用鸡胚源细胞系繁殖传染性法氏囊病毒制备灭活疫苗和联苗的方法 With embryo-derived cell line propagation infectious bursal disease virus vaccine preparation of inactivated vaccines and associated methods
11/30/2011	CN102258776A 猪肺炎支原体、猪鼻支原体二联灭活疫苗及其制备方法 Mycoplasma hyopneumoniae, Mycoplasma hyorhinis two inactivated vaccine and its preparation method
11/30/2011	CN102258775A 一种治疗牛种布鲁氏菌病的重组牛痘病毒疫苗及其制备方法 A cattle brucellosis recombinant vaccinia virus vaccine and its preparation method of treatment
11/30/2011	CN102258774A 布氏杆菌病活疫苗的制备方法及其产品 Preparation brucellosis vaccine and its products
11/30/2011	CN102258773A 酪氯酸蛋白激酶受体EphA2优势表位复合物及其制备方法和应用 Acid casein kinase receptor EphA2 epitope compound and preparation method and application
11/30/2011	CN102258772A 一种新的肿瘤树突状细胞治疗性疫苗的制备方法及其用途 A new cancer therapeutic dendritic cell vaccine preparation and use
11/30/2011	CN102258539A 预防鸭瘟的蜂胶注射液及其制备方法 Propolis injection and its preparation method for the prevention of plague
11/30/2011	CN102258537A 鸡传染性法氏囊病特异性转移因子的制备方法 Preparation of IBD-specific transfer factor
11/30/2011	CN102258500A 流感口服缓释疫苗及其制备方法 Influenza vaccine and oral sustained-release preparation
11/30/2011	CN102258464A 高浓度抗体和蛋白制剂 High concentrations of antibody and protein formulations
11/30/2011	CN101607081B 布鲁氏菌疫苗及疫苗用抗原蛋白的制备方法 Brucella vaccines and vaccine antigen protein preparation method
11/30/2011	CN101580537B 一种人巨细胞病毒ul49基因抗原肽、及其抗体与应用 A human cytomegalovirus gene ul49 antigen peptide, and antibody and application
11/30/2011	CN101502649B 一种脂质体流感疫苗 Liposome influenza vaccine
11/30/2011	CN101311191B 抗人淋巴细胞免疫球蛋白的制备方法 Anti-human lymphocyte immune globulin preparation
11/30/2011	CN101296706B Il-23和il-17拮抗剂治疗自身免疫性眼部炎性疾病的用途 Il-23 and il-17 antagonist in the treatment of autoimmune ocular inflammatory disease use of
11/29/2011	US8067566 Dengue serotype 2 attenuated strain
11/29/2011	US8067565 Dengue serotype 1 attenuated strain
11/29/2011	US8067564 Methods of obtaining a specific binding member that binds eotaxin
11/29/2011	US8067559 Yeast-based vaccines as immunotherapy
11/29/2011	US8067550 Hybridomas producing antibodies against non functional P2X7 receptor
11/29/2011	US8067549 Humanized antibodies and compositions for binding sphingosine-1-phosphate
11/29/2011	US8067548 Fusion proteins having mutated immunoglobulin hinge region
11/29/2011	US8067546 Humanized anti-CD70 binding agents and uses thereof
11/29/2011	US8067544 anticarcinogenic agents; antiproliferative agent; monoclonal, chimeric and/or fully human antibodies
11/29/2011	US8067538 Gene related to growth promoting function of acetic acid bacterium, acetic acid bacterium bred using the gene and method for producing vinegar using the acetic acid bacterium
11/29/2011	US8067535 Identification of gene sequences and proteins involved in vaccinia virus dominant T cell epitopes
11/29/2011	US8067396 Amino alcohol compounds or phosphonic acid derivatives thereof
11/29/2011	US8067376 Pharmaceutical compositions for transdermal delivery
11/29/2011	US8067373 Therapeutic fibrin-derived peptides and uses thereof
11/29/2011	US8067371 Receptor for Advanced Glycation Endproducts (RAGE); rheumatoid arthritis; solubility
11/29/2011	US8067247 Use of anti-CD100 antibodies for the treatment of inflammatory disorders affecting the central or peripheral nervous system
11/29/2011	US8067228 Nucleic acid compositions and their use against the hepatitic C virus
11/29/2011	US8067221 Von Willebrand factor (vWF)-cleaving protease
11/29/2011	US8067203 Composition for treating porcine progressive atrophic rhinitis and making process thereof
11/29/2011	US8067199 Anti-IL13 antibodies and uses thereof
11/29/2011	US8067149 Using stabilizer solutions; removal of cells
11/29/2011	US8067017 Preservation of bioactive materials by freeze dried foam
11/29/2011	US8067016 Fusion proteins of Mycobacterium tuberculosis
11/29/2011	US8067015 Delivery device for topical, oral, intravenous, intraperitoneal, intramuscular, transdermal, nasal, or iontophoretic administration coated with a RNAIII inhibiting heptapeptide of the sequence Tyr-X2-Pro-X1-Thr-Asn-Phe where X1 is Cys, Trp or Ile, and X2 is Lys or Ser; antibiotic resistance

1 ... 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 ... 1823